It slips quietly into coffee cups and protein bars, into chewing gum and “sugar-free” desserts, promising indulgence without consequence. For years, it has been framed as a gentler choice — a way to satisfy sweetness while sidestepping sugar’s long shadow. But new research has cast an unexpected light on this familiar ingredient, inviting a pause in how confidently it has been embraced.
The sweetener in question is erythritol, a low-calorie sugar alcohol commonly used in reduced-sugar foods. In a recent peer-reviewed study, researchers found that higher levels of erythritol in the blood were associated with a significantly increased risk of heart attack and stroke. What unsettled scientists further was how quickly effects appeared: laboratory testing suggested that erythritol could enhance blood clot formation shortly after consumption, offering a possible explanation for the elevated risk seen in patients.
The findings did not emerge from casual observation. Researchers analyzed blood samples from thousands of people over time and noticed that those with the highest erythritol levels faced a greater likelihood of major cardiovascular events. To understand why, they moved into controlled experiments, where erythritol appeared to make platelets more prone to clot — a process closely linked to heart attacks and ischemic strokes.
Still, the picture is not one of simple cause and effect. Scientists emphasize that the study shows association, not definitive causation, and that erythritol is also naturally produced by the human body in small amounts. The concern, they say, lies in large, concentrated doses — the kind that can come from heavily sweetened processed foods and beverages marketed as healthier alternatives.
Nutrition experts not involved in the research have urged caution rather than panic. Artificial and low-calorie sweeteners have long been used by people managing diabetes, obesity, or metabolic conditions, and many clinical trials have shown benefits when they replace sugar. Yet this study adds to a growing sense that “less sugar” does not always mean “no risk”, and that the biology of substitutes can be more complex than their labels suggest.
Regulatory agencies have not changed guidance in response to the findings, but some researchers are calling for more transparency around quantities and for further studies examining short-term and long-term cardiovascular effects. They also stress that dietary patterns matter more than any single ingredient — a reminder often repeated, yet easy to overlook amid the promise of easy fixes.
For consumers, the research lands less as a verdict and more as a moment of reconsideration. The modern diet is full of quiet trade-offs, and erythritol’s story may be another example of how solutions designed to solve one problem can, in time, reveal new questions.
As scientists continue to explore the findings, the takeaway remains measured: moderation, attentiveness, and a willingness to revisit assumptions — even about the most familiar sweetness.
AI Image Disclaimer Images in this article are AI-generated illustrations, meant for concept only.
Sources (media names only) Reuters CNN Health NBC News The Washington Post Nature Medicine
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.




